Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pain Physician

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 28934780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NEUROPATHIC PAIN SECTION Original Research Articles Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial

  2016cited by this paper
• Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

  2015cited by this paper
• Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

  2015influential reference
• No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk

  2015cited by this paper
• A potted history

  2015influential reference
• Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.

  2015influential reference
• Medical Use of Cannabinoids--Reply.

  2015cited by this paper
• Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

  2015cited by this paper
• The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.

  2015cited by this paper
• Classification of neuropathic pain in cancer patients

  2015cited by this paper
• Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

  2015influential reference
• Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

  2015cited by this paper
• Medical marijuana: Showdown at the cannabis corral

  2015cited by this paper
• Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.

  2015cited by this paper
• Comparison of complementary and alternative medicine with conventional mind–body therapies for chronic back pain: protocol for the Mind–body Approaches to Pain (MAP) randomized controlled trial

  2014cited by this paper
• Active, Self-Care Complementary and Integrative Medicine Therapies for the Management of Chronic Pain Symptoms: A Rapid Evidence Assessment of the Literature

  2014cited by this paper
• The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study

  2014cited by this paper
• Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

  2014cited by this paper
• A double‐blind, randomized, placebo‐controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment

  2014cited by this paper
• A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.

  2014cited by this paper
• The Endocannabinoid System, Cannabinoids, and Pain

  2013cited by this paper
• Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews.

  2013cited by this paper
• A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

  2013cited by this paper
• The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms

  2013cited by this paper
• Low-dose vaporized cannabis significantly improves neuropathic pain.

  2013influential reference
• A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis

  2013cited by this paper
• Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results

  2013cited by this paper
• Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

  2012influential reference
• Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial

  2012influential reference
• MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

  2012influential reference
• Phenytoin for neuropathic pain and fibromyalgia in adults.

  2012cited by this paper
• COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS

  2012cited by this paper
• Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

  2012influential reference
• Neuromodulators for pain management in rheumatoid arthritis.

  2012cited by this paper
• An enriched‐enrolment, randomized withdrawal, flexible‐dose, double‐blind, placebo‐controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

  2012cited by this paper
• An efficient randomised, placebo‐controlled clinical trial with the irreversible fatty acid amide hydrolase‐1 inhibitor PF‐04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

  2012cited by this paper
• PHENYTOIN FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS

  2012cited by this paper
• CLONAZEPAM FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS

  2012cited by this paper
• Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

  2011cited by this paper
• Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

  2011cited by this paper
• Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

  2011cited by this paper
• TITLE : Cannabinoids for the Management of Neuropathic Pain : Review of Clinical Effectiveness

  2010cited by this paper
• Review on clinical studies with cannabis and cannabinoids 2005-2009

  2010cited by this paper
• Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury: A Pilot Study

  2010influential reference
• Adverse health effects of non-medical cannabis use.

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

  2010cited by this paper
• Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

  2010influential reference
• Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

  2010influential reference
• Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

  2009influential reference
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Systematic review and meta-analysis of cannabis treatment for chronic pain.

  2009cited by this paper
• Adverse health effects of non-medical cannabis use.

  2009cited by this paper
• Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy

  2009cited by this paper
• Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

  2008cited by this paper
• Nabilone for the treatment of pain in fibromyalgia.

  2008influential reference
• Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.

  2008influential reference
• Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

  2008cited by this paper
• Cannabinoids for the treatment of neuropathic pain: clinical evidence.

  2008cited by this paper
• A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.

  2008influential reference
• Complementary Therapies for Neuropathic and Neuralgic Pain: Systematic Review

  2008cited by this paper
• Role of cannabinoids in the management of neuropathic pain.

  2008cited by this paper
• Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

  2008cited by this paper
• Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.

  2008cited by this paper
• Cannabis in painful HIV-associated sensory neuropathy

  2007influential reference
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain

  2007influential reference
• Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double‐blind, placebo‐controlled clinical trial

  2007influential reference
• Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

  2006cited by this paper
• Effects of nabilone, a synthetic cannabinoid, on postoperative pain

  2006influential reference
• Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

  2006cited by this paper
• [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].

  2006cited by this paper
• Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain

  2006cited by this paper
• Cannabinoids in medicine: A review of their therapeutic potential.

  2006cited by this paper
• [Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].

  2006cited by this paper
• Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain

  2006cited by this paper
• Cannabinoids as therapeutics.

  2005cited by this paper
• Pain measurements and side effect profile of the novel cannabinoid ajulemic acid.

  2005influential reference
• Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

  2005cited by this paper
• Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

  2005influential reference
• Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

  2004influential reference
• Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies

  2004influential reference
• Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

  2004influential reference
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

  2003influential reference
• Cannabis use for chronic non‐cancer pain: results of a prospective survey

  2003cited by this paper
• Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.

  2003cited by this paper
• Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

  2003influential reference
• Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

  2003influential reference
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003influential reference
• Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

  2003cited by this paper
• The Numeric Rating Scale for Clinical Pain Measurement: A Ratio Measure?

  2003cited by this paper
• Safety, tolerability, and efficacy of orally administered cannabinoids in MS

  2002cited by this paper
• Transitions in the Concept of Chronic Pain

  2002cited by this paper
• Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

  2001cited by this paper
• Defining the clinically important difference in pain outcome measures

  2000cited by this paper
• Pain relief with oral cannabinoids in familial Mediterranean fever

  1997influential reference
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• PATIENTS AND METHODS

  1990influential reference
• The Subjective Experience of Acute Pain An Assessment of the Utility of 10 Indices

  1989cited by this paper

• Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis

  2025cites this paper
• Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011–2025

  2025cites this paper
• Subjective drug-effect ratings predict cannabis self-administration in people who use cannabis daily.

  2025cites this paper
• The influence of genetics on the endocannabinoid system gene expression and relevance for targeting reproductive conditions

  2025cites this paper
• The Present and Future of Pain Management in Patients With Chronic Kidney Disease: A Narrative Review

  2025cites this paper
• Optimization of Solvent Mixture for Solubilizing Cannabis Extract Using I-Optimal Design

  2025cites this paper
• Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines

  2025cites this paper
• Therapeutic potential of cannabidiol in oral disorders: A systematic review of clinical evidence.

  2025cites this paper
• Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectations

  2025cites this paper
• The Efficacy and Safety of Use of Cannabis and Cannabinoid Products for Pain Relief in Orthopaedic Conditions and Trauma

  2025cites this paper
• Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential

  2025cites this paper
• Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease

  2025cites this paper
• Evaluation of a Digital Educational Intervention to Enhance Oncology Nurse Professional Practice to Support Safe Cannabis Use: A Pilot Study.

  2025cites this paper
• Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping Review

  2025cites this paper
• Looking beyond traditional pain outcomes to better evaluate cannabis's true potential and limitations in chronic pain management.

  2025cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS–STING Pathway in Triple-Negative Breast Cancer Cells

  2024cites this paper
• Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice

  2024cites this paper
• Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness

  2024cites this paper
• Cannabis Co-Use Among Black Individuals with Chronic Pain Who Use Opioids: Associations with Other Substance Use and Pain Related Outcomes

  2024cites this paper
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology

  2024cites this paper
• The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial

  2024cites this paper
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  2024cites this paper
• Impact of Medical Cannabis on Recovery from Playing-Related Musculoskeletal Disorders in Musicians: An Observational Cohort Study

  2024cites this paper
• The clinical use of cannabinoids for pain

  2024cites this paper
• Pain symptoms are associated with two-point discrimination threshold in patients with temporomandibular disorders

  2024cites this paper
• Prevalence and Effect of Cannabinoids in Pain Management for Hand Pathologies

  2024cites this paper
• An early economic analysis of medical cannabis for the treatment of chronic pain

  2024cites this paper
• The Potential of Cannabichromene (CBC) as a Therapeutic Agent

  2024cites this paper
• Cannabis use on gingival bleeding and caries experience among students

  2024cites this paper
• Perceptions, Uses, and Information Sources of Medical Cannabis Among Patients With Cancer

  2024cites this paper
• Natural Products Derived from Cannabis sativa for Pain Management.

  2024cites this paper
• Physicochemical Properties, Heavy Metal and Pesticide Contaminations, and Microbial Limit Tests of Cannabis Oral Drops

  2024cites this paper
• The Use of Recreational Cannabis Among Breast Reduction Patients: Characteristics, Complications, and Immediate Postoperative Analgesic Needs

  2024cites this paper
• Cannabinoid and Serotonergic Systems: Unraveling the Pathogenetic Mechanisms of Stress-Induced Analgesia

  2024cites this paper
• Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment

  2024cites this paper
• Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials

  2024cites this paper
• Applications of Cannabinoids in Neuropathic Pain: An Updated Review.

  2024cites this paper
• A Preliminary Study Looking at the Use of Mindful Compassion and Cannabis Suppositories for Anodyspareunia among Men Who Have Sex with Men (MSM)

  2024cites this paper
• ACOG Clinical Consensus No. 7: The Use of Cannabis Products for the Management of Pain Associated With Gynecologic Conditions

  2024cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Cannabinoids in anesthesia and chronic pain: Where do we stand?

  2024cites this paper
• Medical Cannabis Prescription Practices and Quality of Life in Thai Patients: A Nationwide Prospective Observational Cohort Study

  2024cites this paper
• Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

  2023cites this paper
• Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators.

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 2

  2023cites this paper
• Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

  2023cites this paper
• Veterans and Medical Cannabis: A Perfect Federalism Storm

  2023cites this paper
• Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications

  2023cites this paper
• Current update on multimodal analgesia and nonopiate surgical pain management.

  2023cites this paper
• Perceived Effectiveness of Medical Cannabis Among Adults with Chronic Pain: Findings from Interview Data in a Three-Month Pilot Study

  2023cites this paper
• Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

  2023cites this paper
• Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Counting your chickens before they hatch: improvements in an untreated chronic pain population, beyond regression to the mean and the placebo effect

  2023cites this paper
• Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey

  2023cites this paper
• Conference on Advances in Pharmacovigilance for Herbal Medicines 12th–14th April 2023

  2023cites this paper
• Cannabis use among adults undergoing cancer treatment

  2023cites this paper
• Developing Prediction Models Using Near-Infrared Spectroscopy to Quantify Cannabinoid Content in Cannabis Sativa

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 3

  2023cites this paper
• MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events

  2023cites this paper
• Is Cannabis Effective in the Treatment of Chronic Back Pain?

  2023cites this paper
• Neuropathic pain: Mechanisms and therapeutic strategies

  2023cites this paper
• Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

  2023cites this paper
• Cannabis and male sexual health: contemporary qualitative review and insight into perspectives of young men on the internet.

  2023cites this paper
• The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice

  2023cites this paper
• Medical Cannabis: A Review from the American Society of Pain and Neuroscience

  2023cites this paper
• Mental disorders are no predictors to determine the duration of cannabis-based treatment for chronic pain

  2023cites this paper
• Prescription Practices of Cannabinoids in Children with Cerebral Palsy Worldwide—A Survey of the Swiss Cerebral Palsy Registry

  2023cites this paper
• Cannabidiol and Tetrahydrocannabinol Antinociceptive Activity is Mediated by Distinct Receptors in Caenorhabditis elegans

  2023cites this paper
• Consumer perception, knowledge, and uses of cannabidiol

  2023cites this paper
• Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse

  2023cites this paper
• Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 4

  2023cites this paper
• The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain

  2023cites this paper
• Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks

  2023cites this paper
• Cannabis for Rheumatic Disease Pain: a Review of Current Literature

  2022cites this paper
• Cannabis Use Is Associated With Increased Use of Prescription Opioids Following Posterior Lumbar Spinal Fusion Surgery

  2022cites this paper
• Cannabinoid Use for Pain Reduction in Spinal Cord Injuries: A Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain

  2022cites this paper
• Cannabis and Cannabinoids in the Perioperative Period

  2022cites this paper
• Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey

  2022cites this paper
• Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma

  2022cites this paper
• From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome

  2022cites this paper
• Cannabis-based medicines for prevention of postoperative nausea and vomiting in adults

  2022cites this paper
• Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review

  2022cites this paper
• Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler

  2022cites this paper
• Substances psychoactives : tabac, alcool, psychotropes et drogues illicites – impact sur la santé orale

  2022cites this paper
• Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists

  2022cites this paper
• AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis

  2022cites this paper
• Surveying Canadian Pain Physicians’ Attitudes and Beliefs Regarding Medical Cannabis for Chronic Noncancer Pain: A Qualitative Study

  2022cites this paper
• The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study

  2022cites this paper
• Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain

  2022cites this paper
• Savoring as an intervention for cannabis use: acceptability, feasibility, and preliminary results

  2022cites this paper
• Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real‐world study

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 1, September 2022

  2022cites this paper
• Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  2022cites this paper
• Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates.

  2022cites this paper
• Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology.

  2022cites this paper
• Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review

  2022cites this paper